SCHEMBL3962646

SCHEMBL3962646

CC(C)(C(=O)Nc1cc2ccccc2cn1)S(=O)(=O)c1ccc(F)cc1F.CC(C)(C(=O)Nc1nc(-c2cccnc2)cs1)S(=O)(=O)c1ccc(F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
ALDH1A1 P00352 3/20 0.45
HTT P42858 2/20 0.45
KMT2A Q03164 6/20 0.44
MAPT P10636 5/20 0.43
MEN1 O00255 5/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPK1 P28482 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
RECQL P46063 1/20 0.43
PKM P14618 1/20 0.43
GAA P10253 1/20 0.43
TDP1 Q9NUW8 3/20 0.43
CNR2 P34972 1/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP1B1 Q16678 1/20 0.42
ROCK1 Q13464 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1464561 0.91 SMN1; SMN2 (0.53) SMN1; SMN2RAB9ANPC1ALDH1A1HTT
SCHEMBL3963509 0.88 AGTR1 (0.54) SMN1; SMN2RAB9ANPC1ALDH1A1HTT
SCHEMBL1465574 0.84 CNR2 (0.56) CNR2
SCHEMBL1463755 0.80 AGTR1 (0.62) SMN1; SMN2RAB9ANPC1ALDH1A1HTT
SCHEMBL1463644 0.77 ABL1 (0.53) SMN1; SMN2KMT2AMAPTMEN1MAPK1
SCHEMBL1466154 0.75 MEN1 (0.53) SMN1; SMN2RAB9ANPC1ALDH1A1KMT2A
SCHEMBL1464642 0.75 CNR2 (0.54) CNR2
SCHEMBL3965000 0.74 CNR2 (0.50) CNR2LMNA
SCHEMBL1464917 0.72 MEN1 (0.64) SMN1; SMN2RAB9ANPC1ALDH1A1HTT
SCHEMBL1621153 0.72 ALDH1A1 (0.55) SMN1; SMN2RAB9ANPC1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP claimed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO claimed